A “search and destroy” treatment has been found to halt tumours in some men with incurable prostate cancer. The early-stage ...
3don MSN
Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery, study finds
A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to ...
A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, with patients who had previously stopped being receptive to treatment finding their tumours shrinking, ...
AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the novel Phase 2 design of the ongoing TheraPb clinical trial of ...
Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that ...
At 7.3 years’ median follow-up, cabazitaxel failed to improve clinical PFS (62.8% vs 67.2%), metastasis-free survival, or overall survival versus androgen deprivation therapy plus radiotherapy.
Vir Biotechnology lands a license agreement with Japan’s Astellas Pharma for its lead drug candidate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results